Skip to content
10-Q

Quarterly Report

MARIZYME, INC.

0001493152-24-021617

← back to feed
Filed
May 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 28, 2024 131.79M sh
Shares Diluted Q1 2024 · Mar 31, 2024 131.79M sh
Shares Diluted Q1 2024 · Mar 31, 2023 40.76M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$808.95K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$1.12M
Stockholders Equity Q1 2024 · Mar 31, 2024 −$10.83M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$4.66M
Stockholders Equity Q1 2024 · Mar 31, 2023 $15.23M
Stockholders Equity Q1 2024 · Dec 31, 2022 $17.42M
Current Liabilities Q1 2024 · Mar 31, 2024 $25.85M
Current Liabilities Q1 2024 · Dec 31, 2023 $20.6M
Total Liabilities Q1 2024 · Mar 31, 2024 $32.4M
Total Liabilities Q1 2024 · Dec 31, 2023 $26.68M
Current Assets Q1 2024 · Mar 31, 2024 $734.99K
Current Assets Q1 2024 · Dec 31, 2023 $968.78K
Total Assets Q1 2024 · Mar 31, 2024 $21.57M
Total Assets Q1 2024 · Dec 31, 2023 $22.02M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.05
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.06
Eps Basic Q1 2024 · Mar 31, 2024 −$0.05
Eps Basic Q1 2024 · Mar 31, 2023 −$0.06
Rd Expense Q1 2024 · Mar 31, 2024 $321.87K
Rd Expense Q1 2024 · Mar 31, 2023 $606K
Net Income Q1 2024 · Mar 31, 2024 −$6.23M
Net Income Q1 2024 · Mar 31, 2023 −$2.55M
Operating Income Q1 2024 · Mar 31, 2024 −$1.37M
Operating Income Q1 2024 · Mar 31, 2023 −$2.13M
Gross Profit Q1 2024 · Mar 31, 2024 $23.21K
Gross Profit Q1 2024 · Mar 31, 2023 $89.7K
Cost Of Revenue Q1 2024 · Mar 31, 2024 $9.65K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $39.28K
Revenue Q1 2024 · Mar 31, 2024 $32.86K
Revenue Q1 2024 · Mar 31, 2023 $128.97K